British health economist Karl Claxton warned that pressure from Donald Trump could lead people in the United Kingdom to pay twice as much for branded medicines. He described the possible impact on healthcare as catastrophic.

Claxton also said the situation should serve as a warning to Europe, where he said the United States now has influence over similar trade agreements and decisions have been made without parliamentary control.